| Pharmaceutical active ingredients: |
| Norethindrone |
| Available forms, composition and doses of Proluteasi: |
| N / A |
| Proluteasi medical category: |
| Human:ContraceptivesOestrogens and progesterones and related synthetic drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AC01 - NorethisteroneG03DC02 - Norethisterone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Prolets | Progesterone | Unidentified Pharmaceutical Company |
| Prolixin Concentrate | Fluphenazine | Unidentified Pharmaceutical Company |
| Prolixine | Fluphenazine | Unidentified Pharmaceutical Company |
| Prolongine | Probenecid | Unidentified Pharmaceutical Company |
| Proloxin | Mephenesin | Unidentified Pharmaceutical Company |
| Prolutin | Progesterone | Unidentified Pharmaceutical Company |
| Prolutol | Ethisterone | Unidentified Pharmaceutical Company |
| Proluton C | Ethisterone | Unidentified Pharmaceutical Company |
| Promacortine | Methylprednisolone | Unidentified Pharmaceutical Company |
| Promacot | Promethazine Hydrochloride | Unidentified Pharmaceutical Company |